Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA TrialTheodore W. Laetsch, Stephan A. Grupp, Henrique Bittencourt et al.|Journal of Clinical Oncology|2022Cited by 369
S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDYSusana Rives, S. Grupp, Shannon L. Maude et al.|HemaSphere|2022Cited by 37